Live Breaking News & Updates on Calcific Uremic Arteriolopathy

Barcelona, Spain, November 23, 2021 – Caixa Capital Risc, the venture capital subsidiary of CriteriaCaixa, today announces the sale of its portfolio company Sanifit Therapeutics to Vifor Pharma, a global pharmaceutical company that aims to become an industry leader in iron deficiency, nephrology and cardio-renal the. ....

Comunidad Autonoma De Cataluna , Pablo Cironi , Joan Perell , Vifor Pharma , Boehringer Ingelheim , Malta Life Sciences , Centre For The Development Of Industrial Technology , Swiss Stock Exchange , Swiss Exchange , University Of The Balearic , Vifor Pharma Group , Fresenius Medical Care , Caixa Capital Risc , Sanifit Therapeutics , Balearic Islands , Calcific Uremic Arteriolopathy , Peripheral Artery Disease , Capital Risc , Caixa Capital , Caixa Capital Risk , Criteria Bio Ventures , Northern Biologics , Foreign Direct Investment , Uremic Arteriolopathy , End Stage Renal Disease , Cardiovascular Calcification ,